In a pivotal move, Syrian government forces have deployed in the northeastern city of Hasakah, following a U.S.-backed agreement with the Kurdish-led Syrian Democratic Forces (SDF) to integrate their forces, signaling a major realignment in the war-torn region.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
A weekend of major headlines saw federal arrests of journalists, a new batch of Epstein files, and a divisive documentary debut, sparking intense debate about legal boundaries and media responsibility.
Despite a post-earnings slump and near 52-week lows, Abbott Laboratories' resilient medical device unit, strategic expansion in diabetes care, and a landmark acquisition in cancer diagnostics paint a promising long-term picture for this Dividend Aristocrat.
Pharmaceutical giant Eli Lilly is investing $3.5 billion to build a new manufacturing facility in rural Pennsylvania, marking its latest move in a massive U.S. expansion aimed at meeting soaring demand for next-generation obesity treatments and capitalizing on reshoring incentives.
Maine moves to establish a novel regulatory framework for on-demand pay services, while Washington, D.C. debates whether to treat them as loans, highlighting a national struggle to oversee this fast-growing fintech sector.
Live cattle futures closed mostly lower Friday, pressured by a key government report showing a slight decline in the national cattle inventory. While cash markets showed some resilience, the data points to ongoing tightness in beef supplies.
Federal authorities have made two additional arrests linked to the January disruption of a Minnesota church service, as legal and First Amendment debates intensify around the case involving anti-ICE demonstrators and journalists.
MTF Enterprises, operator of 43 Subway locations, enters bankruptcy protection, alleging that aggressive lending practices crippled its finances. The case highlights growing tensions within the franchise model and the risks of alternative small-business financing.
Egypt reopened the Rafah border crossing on Tuesday, allowing the first medical evacuation from Gaza since its latest closure. A critically wounded Palestinian patient was transferred to an Egyptian hospital, amid ongoing hostilities in the Strip.
President Trump's selection of Kevin Warsh to lead the Federal Reserve has bolstered the dollar and triggered a sharp sell-off in gold and silver, raising questions about the future of the metals trade amid shifting monetary policy expectations.
Target's Michael Fiddelke and Walmart's John Furner step into the CEO role, outlining priorities to reinvigorate growth and customer loyalty amid operational and social challenges.
Facing pressure from both investors and regulators, banks and wealth managers are turning to pass-through voting mechanisms to reclaim shareholder influence and align stewardship with client values, even within passively managed funds.
Forty years after Reagan and Gorbachev's historic meeting in Iceland envisioned a world free of nuclear weapons, expired treaties, rising stockpiles, and new global players are fueling a dangerous relapse.
Equinor's stock has gained ground over the past month, yet a detailed fair value analysis suggests the Norwegian energy giant may be trading at a premium. Investors are weighing strong long-term momentum against future headwinds from the green shift.
Stephens lowers price target on Cal-Maine Foods (CALM) citing near-term oversupply pressures, but the egg producer's long-term strategy remains focused on expanding its cage-free capacity through acquisition.
Aptiv PLC sees mixed but upwardly revised price targets from major analysts, with Piper Sandler upgrading the auto tech supplier to Overweight and naming it a top pick for 2026, citing its pragmatic strategy and attractive valuation.
H.C. Wainwright and Chardan Capital upgrade Korro Bio (KRRO) to Buy, citing the independent potential of its RNA-editing asset KRRO-121 and strong preclinical data as key catalysts.
Alibaba's logistics arm Cainiao is making a major strategic move into autonomous freight, with a reported $2 billion investment in L4 self-driving truck firm Zelos Technology, signaling a deepening push into AI-driven supply chain solutions.
Canadian junior miner G2 Goldfields Inc. (TSX: GTWO), despite recent losses, is projected by analysts to reach profitability within two years, backed by aggressive growth forecasts and a debt-free balance sheet.
